-
SFDA releases 2009 Annual Report on Drug Registration ApprovalThe State Food and Drug Administration (SFDA) recently officially released the 2009 Annual Report on Drug Registration Approval. The Annual Report consists of six parts: the drug registration manageme2010/9/29
-
FDA approves combination contraceptive containing a folateThe U.S. Food and Drug Administration today approved Beyaz tablets, an estrogen/progestin combined oral contraceptive that also contains a folate (levomefolate calcium 0.451 mg). Levomefolate calci2010/9/28
-
FDA significantly restricts access to the diabetes drug AvandiaMakes regulatory decisions on RECORD and TIDE trials The U.S. Food and Drug Administration today announced that it will significantly restrict the use of the diabetes drug Avandia (rosiglitazone)2010/9/28
-
BASF increases prices for automotive fluids globallyBASF increases prices for automotive fluids globally Ludwigshafen, Germany – September 24, 2010 – With immediate effect, or as contracts allow, BASF is increasing the sales prices globally for all2010/9/27
-
AVENEER® - Construction of the first MMA production plant slated for 2014 – location to be decided on in 2011AVENEER® - Construction of the first MMA production plant slated for 2014 – location to be decided on in 2011 Catalytic process improves ACH yield by up to 10 percent AVENEER® reduces2010/9/27
-
Turbo test for chemical catalystsTurbo test for chemical catalysts 2010-09-21 P-10-413 Prof. Ferdi Schüth (MPI für Kohlenforschung, Mülheim), Dr. Dirk Demuth and Dr. Wolfram Stichert (hte AG, Heidelberg) have been nominated fo2010/9/26
-
Consumers need to be made aware of benefits of low-calorie sweetenersLeading experts in the field of food additive safety and risk communication gathered at a symposium hosted today by the Nutrition Research Foundation at the 2nd World Congress of Public Health Nutriti2010/9/26
-
Perrigo files NDA with FDA for generic Zegerid OTCPerrigo Company (Nasdaq: PRGO; TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for omeprazole 20mg/sodium bicarbonate 11002010/9/25
-
Porsolt Announces the Opening of a new Research Centre in the USA.Porsolt announces the continuation of its expansion strategy with the creation of a new preclinical Contract Research facility in San Antonio, Texas.Commencing operations in October 2010, the new faci2010/9/25
-
Genzyme announces Japanese approval of Synvisc viscosupplement for OA knee pain reliefGenzyme Corporation (Nasdaq: GENZ) announced today that Japan's Ministry of Health, Labour and Welfare has approved Synvisc® (hylan G-F 20; 3 x 2 mL), indicated for the treatment of osteoarthritis2010/9/21